Clinical Trials on Renal Anemia of Chronic Kidney Disease in Canada

Total 779 results

Argos Therapeutics

Completed

RNA-Loaded Dendritic Cell Cancer Vaccine

Renal Cell Carcinoma

United States, Canada
National Cancer Institute (NCI)

Completed

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific | Stage III Renal Cell Cancer | Recurrent Endometrial Carcinoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer | Stage IV Endometrial Carcinoma | Stage III Endometrial Carcinoma | Endometrial Papillary Serous Carcinoma

Canada
McMaster Children's Hospital

Unknown

Use of Sodium Bicarbonate in Patients Treated With Topiramate

Epilepsy | Metabolic Acidosis | Tubular Acidosis; Renal

Canada
C. T. Lamont Primary Care Research Centre

Completed

Chronic Illness Care Management (CICM) Study In Primary Care

Quality of Life | Chronic Illness

Canada
National Institute of Diabetes and Digestive and...
Long Island Jewish Medical Center

Terminated

Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome

Hemolytic Uremic Syndrome

United States, Canada
Sunnybrook Health Sciences Centre
Pfizer

Completed

Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib

Clear Cell Metastatic Renal Cell Carcinoma

Canada
Ottawa Hospital Research Institute
The Physicians' Services Incorporated Foundation; The Kidney Foundation of... and other collaborators

Recruiting

Albumin To Enhance Recovery After Acute Kidney Injury (ALTER-AKI)

Critical Illness | Acute Kidney Injury | Hypotension | Renal Replacement Therapy

Canada
Maisonneuve-Rosemont Hospital

Completed

Optimal Administration of Allopurinol in Dialysis Patients

Renal Insufficiency | Gout

Canada
CRISPR Therapeutics AG

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC)

Renal Cell Carcinoma

United States, Australia, Canada, Netherlands
AstraZeneca
SCRI Development Innovations, LLC

Completed

A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC)

Papillary Renal Cell Cancer

United States, Canada, United Kingdom, Spain
Mayo Clinic

Completed

"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones

Kidney Calculi | Nephrolithiasis | Kidney Stones | Renal Stones

United States, Canada
AstraZeneca

Completed

A Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell Disease (HESTIA 1)

Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease

United States, Canada, United Kingdom, South Africa, Lebanon, Kenya
NCIC Clinical Trials Group
National Cancer Institute (NCI)

Completed

3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma

Kidney Cancer

Canada
Bristol-Myers Squibb

Terminated

A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma

Renal Cell Carcinoma

Canada, United States
Lawson Health Research Institute

Recruiting

Kidney Sodium Content in Cardiorenal Patients

Cardio-Renal Syndrome

Canada
University of Alberta

Completed

Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill (VASTVALUS)

Myocardial Infarction | Stroke | Renal Failure

Canada
MedImmune LLC

Completed

A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies

Kidney Cancer | Clear Cell Renal Cell Carcinoma | Select Advanced Malignancies

United States, France, Canada, United Kingdom, Netherlands, Australia
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)

Renal Cell Carcinoma | Clear-cell Metastatic Renal Cell Carcinoma

United States, Canada
University of Calgary
The George Institute; Applied Health Research Centre

Recruiting

ACCESS HD: Comparing Catheters to Fistulas in Elderly Patients Starting Hemodialysis (ACCESS HD)

End-stage Kidney Failure

Canada, Australia
Lawson Health Research Institute

Completed

Relationship of Ochratoxin A to Upper Urologic Cancers

Transitional Cell Carcinoma | Renal Cell Cancer | Testicular Cancer

Canada
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients

Graft Rejection | Kidney Failure

United States, Spain, Canada, Switzerland, Austria, Australia, New Zealand
University of Alberta

Completed

Trying Activity in Kidney Cancer Survivors (TRACKS) Trial (TRACKS)

Supervised Physical Activity Plus Exercise Counseling | Supervised Physical Activity Plus Behavioural Counseling

Canada
AHS Cancer Control Alberta

Terminated

[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours

Renal Cell Carcinoma | Neuroendocrine Tumours

Canada
Sunnybrook Health Sciences Centre

Completed

Renal Atherosclerotic Revascularization Evaluation: RAVE Study

Hypertension, Renovascular

Canada
Hamilton Health Sciences Corporation
Juravinski Cancer Centre Foundation

Recruiting

Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief (SOLAR-P)

Melanoma | Renal Cell Carcinoma | Breast Cancer | Prostate Cancer | Bone Metastases

Canada
Ottawa Hospital Research Institute
The Ottawa Hospital

Unknown

Safety Study of Enoxaparin Prophylaxis in Critically Ill Adults With Severe Renal Insufficiency

Hemorrhage

Canada
University of British Columbia

Completed

The Quality of Life and Direct Financial Costs Associated With Home Ventilation of Children: A Prospective Study

Children Receiving Ventilation at Home for Chronic Illness or Disease

Canada
Alexion Pharmaceuticals

Terminated

aHUS Observational Long Term Follow-Up (LTFU)

Atypical Hemolytic Uremic Syndrome

France, Canada, United States, Belgium, Italy, United Kingdom, Netherlands, Australia, Austria, Germany, Sweden, Switzerland
Mansoura University

Recruiting

Evaluation of Prevalence, Molecular and Genetic Backgrounds of Calcium-Based Stones Among Patients With Renal Calcular Disease in Mansoura Urology and Nephrology Center

Renal Calculi

Egypt
Argos Therapeutics

Completed

Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney Cancer

Renal Cell Carcinoma

Canada, United States
Université de Sherbrooke
Canadian Institutes of Health Research (CIHR)

Recruiting

Surveillance of Complex Renal Cysts - The SOCRATIC Study (SOCRATIC)

Complex Renal Cyst

Canada, France
Centre de Recherche de l'Institut Universitaire...
Canadian Institutes of Health Research (CIHR)

Completed

Trial Applying Policy to Eliminate or Reduce Inappropriate Narcotics in the General-population (TAPERING)

Health Behavior | Pain, Chronic | Inappropriate Dose of Drug Administered

Canada
National Cancer Institute (NCI)

Active, not recruiting

Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2 | Myelodysplastic Syndrome With Excess Blasts-1 | Myelodysplastic Syndrome/Acute Myeloid Leukemia

Canada, United States
University of Calgary
Alberta Health services; University of Alberta; Alberta Innovates Health Solutions

Completed

Contrast RISK (Reducing Injury Sustained by Kidneys) (Contrast RISK)

Coronary Artery Disease | Acute Kidney Injury (Nontraumatic)

Canada
Spanish Oncology Genito-Urinary Group

Completed

Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib (Spazo-2)

Metastatic Renal Cell Carcinoma

Spain
Eli Lilly and Company

Recruiting

A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk (ACHIEVE-4)

Cardiovascular Diseases | Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | Overweight or Obesity

United States, Italy, Spain, Korea, Republic of, India, Turkey, Austria, Puerto Rico, Mexico, Romania, Brazil, Germany, Argentina, Czechia, Greece, Slovakia
Montreal Heart Institute
The Montreal Health Innovations Coordinating Center (MHICC)

Completed

Portal Flow Pulsatility as a Risk Factor for Acute Kidney Injury After Cardiac Surgery (PP-AKI)

Postoperative Complications | Acute Kidney Injury | Cardio-Renal Syndrome | C.Surgical Procedure; Cardiac | Right-Sided Heart Failure

Canada
Duke University
Novartis; Pfizer

Completed

Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma (ASPEN)

Advanced Non-clear Cell Renal Cell Carcinoma

United States, Canada, United Kingdom
Hamilton Health Sciences Corporation
Hoffmann-La Roche; McMaster University; Canadian Apheresis Group

Unknown

Rituximab in Patients With Relapsed or Refractory TTP-HUS

Thrombotic Thrombocytopenic Purpura | Hemolytic Uremic Syndrome

Canada
Jennerex Biotherapeutics

Completed

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors

Melanoma | Renal Cell Carcinoma | Lung Cancer | Squamous Cell Carcinoma of the Head and Neck

United States, Canada
National Cancer Institute (NCI)

Completed

Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Recurrent Uterine Corpus Sarcoma | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Lung Carcinoid Tumor | Stage IV Renal Cell Cancer | Recurrent Digestive System Neuroendocrine Tumor G1 | Adult Solid Neoplasm | Stage IIIB Uterine Sarcoma | Stage IIIC Uterine Sarcoma | Stage IVA Uterine Sarcoma and other conditions

Canada
Astellas Pharma Global Development, Inc.

Completed

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

United States, Canada
Hamilton Health Sciences Corporation
Pfizer; Canadian Critical Care Trials Group

Completed

Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)

Renal Insufficiency

Canada
National Cancer Institute (NCI)
Glaxosmithkline Biologicals S.A.

Terminated

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Renal Failure | Solid Neoplasm | BRAF Gene Mutation | Hepatic Complication

United States, Canada
AstraZeneca

Terminated

A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia (STABILIZE-CKD)

Renal Insufficiency, Chronic | Hyperkalemia

United States, Italy, Spain, Thailand, Vietnam, Turkey, Canada, Philippines, China, Malaysia, Taiwan, Brazil, Japan, Bulgaria, Russian Federation, Poland, Argentina, Mexico, Ukraine, India, Puerto Rico
Dr. Gordon Boyd

Recruiting

Neurocognitive Outcomes for ICU Patients With Acute Kidney Injury (INCOGNITOAKI)

Delirium | Critical Illness | Cognitive Impairment | Acute Kidney Injury | Cerebral Oxygenation | Cerebral Autoregulation

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect) (SUPER)

Heart Failure | Renal Cell Carcinoma | Hypertension | Cardiotoxicity

Canada
Telix International Pty Ltd

Completed

89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study (89ZR-TLX250)

Clear Cell Renal Cell Carcinoma

United Kingdom, United States, Australia, Turkey, Netherlands, Belgium, Canada, France
Argos Therapeutics

Completed

Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment

Renal Cell Carcinoma

United States, Canada
Elypta

Recruiting

AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC (AUR87A)

Clear Cell Renal Cell Carcinoma

United States, Sweden, United Kingdom, France, Denmark, Finland, Canada, Italy, Portugal, Spain

Clinical Trials on Renal Anemia of Chronic Kidney Disease in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations